Publications by authors named "Pegi Ahlin Grabnar"

Claim this Profile
T
Targeting intermolecular interactions to reduce viscosity in monoclonal antibody formulations: A review.
Monika Prašnikar, Maja Bjelošević Žiberna, Pegi Ahlin Grabnar

Int J Biol Macromol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive effects of the new viscosity-reducing and stabilizing excipients for monoclonal antibody formulation.
Monika Prašnikar, Maja Bjelošević Žiberna, Nika Kržišnik, Robert Roškar, Iztok Grabnar, Pegi Ahlin Grabnar

Int J Pharm· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel strategies in systemic and local administration of therapeutic monoclonal antibodies.
Monika Prašnikar, Maja Bjelošević Žiberna, Mirjam Gosenca Matjaž, Pegi Ahlin Grabnar

Int J Pharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lyophilised protein formulations as a patient-centric dosage form: A contribution toward sustainability paradigm.
Maja Bjelošević Žiberna, Pegi Ahlin Grabnar, Mirjana Gašperlin, Mirjam Gosenca Matjaž

Acta Pharm· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions.
Monika Prašnikar, Matic Proj, Maja Bjelošević Žiberna, Blaž Lebar, Benjamin Knez, Iztok Grabnar, Pegi Ahlin Grabnar

Int J Pharm· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability study.
Jelena R Mitrović, Maja Bjelošević Žiberna, Aleksandar Vukadinović, Daniel E Knutson, Dishary Sharmin, Pegi Ahlin Grabnar

Eur J Pharm Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Quality by Design Principles to the Development of Oral Lyophilizates Containing Olanzapine.
Maja Bjelošević Žiberna, Pegi Ahlin Grabnar

Pharmaceutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excipients in freeze-dried biopharmaceuticals: Contributions toward formulation stability and lyophilisation cycle optimisation.
Maja Bjelošević, Alenka Zvonar Pobirk, Odon Planinšek, Pegi Ahlin Grabnar

Int J Pharm· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The formation and effect of mannitol hemihydrate on the stability of monoclonal antibody in the lyophilized state.
Maja Anko, Maja Bjelošević, Odon Planinšek, Uroš Trstenjak, Manca Logar, Pegi Ahlin Grabnar

Int J Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive conditions during primary drying as a contemporary approach to optimise freeze-drying cycles of biopharmaceuticals.
Maja Bjelošević, Katarina Bolko Seljak, Uroš Trstenjak, Manca Logar, Boris Brus, Pegi Ahlin Grabnar

Eur J Pharm Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and preclinical pharmacokinetics of a novel subcutaneous thermoresponsive system for prolonged delivery of heparin.
Maja Radivojša Matanović, Pegi Ahlin Grabnar, Dario Voinovich, Samuel Golob, Mojca Božič Mijovski, Iztok Grabnar

Int J Pharm· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged subcutaneous delivery of low molecular weight heparin based on thermoresponsive hydrogels with chitosan nanocomplexes: Design, in vitro evaluation, and cytotoxicity studies.
Maja Radivojša Matanović, Iztok Grabnar, Mirjam Gosenca, Pegi Ahlin Grabnar

Int J Pharm· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a simple and sensitive size-exclusion chromatography method for quantitative determination of heparin in pharmaceuticals.
Maja Radivojša Matanović, Iztok Grabnar, Pegi Ahlin Grabnar, Robert Roškar

Acta Pharm· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermoresponsive polymers: insights into decisive hydrogel characteristics, mechanisms of gelation, and promising biomedical applications.
Maja Radivojša Matanović, Julijana Kristl, Pegi Ahlin Grabnar

Int J Pharm· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
Maja Radivojša, Iztok Grabnar, Pegi Ahlin Grabnar

Eur J Pharm Sci· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune reactivity of IgM acquired after oxidation.
Jasna Omersel, Ivica Avberšek-Lužnik, Pegi Ahlin Grabnar, Tanja Kveder, Blaž Rozman

Redox Rep· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural characterization of liposomes made of diether archaeal lipids and dipalmitoyl-L-α-phosphatidylcholine.
Dejan Gmajner, Pegi Ahlin Grabnar, Magda Tušek Znidarič, Jasna Strus, Marjeta Sentjurc

Biophys Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers.
Pegi Ahlin Grabnar, Julijana Kristl

J Microencapsul· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current view on nanosized solid lipid carriers for drug delivery to the skin.
Julijana Kristl, Karmen Teskac, Pegi Ahlin Grabnar

J Biomed Nanotechnol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device.
Alenka Zvonar, Julijana Kristl, Janez Kerc, Pegi Ahlin Grabnar

J Microencapsul· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis